XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2023   11,098,057    
Balance at beginning of period at Dec. 31, 2023 $ 243,079 $ 70,182 $ 211,925 $ (39,028)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 19,763   19,763  
Net unrealized gain on securities available for sale, net of tax 5,181     5,181
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7     7
Net unrealized loss on hedging derivative instruments, net of tax (436)     (436)
Comprehensive income 24,515   19,763 4,752
Cash dividends declared (11,917)   (11,917)  
Equity compensation expense 680 $ 680    
Payment to repurchase common stock (in shares)   (9,081)    
Payment to repurchase common stock (212)   (212)  
Issuance of restricted stock (in shares)   32,859    
Proceeds from sale of common stock (in shares)   26,231    
Proceeds from sale of common stock $ 638 $ 638    
Ending balance (in shares) at Sep. 30, 2024 11,148,066 11,148,066    
Balance at end of period at Sep. 30, 2024 $ 256,783 $ 71,500 219,559 (34,276)
Beginning balance (in shares) at Jun. 30, 2024   11,139,639    
Balance at beginning of period at Jun. 30, 2024 244,668 $ 71,053 215,999 (42,384)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 7,571   7,571  
Net unrealized gain on securities available for sale, net of tax 8,975     8,975
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 2     2
Net unrealized loss on hedging derivative instruments, net of tax (869)     (869)
Comprehensive income 15,679   7,571 8,108
Cash dividends declared (4,011)   (4,011)  
Equity compensation expense 230 $ 230    
Payment to repurchase common stock (in shares)   (200)    
Proceeds from sale of common stock (in shares)   8,627    
Proceeds from sale of common stock $ 217 $ 217    
Ending balance (in shares) at Sep. 30, 2024 11,148,066 11,148,066    
Balance at end of period at Sep. 30, 2024 $ 256,783 $ 71,500 219,559 (34,276)
Beginning balance (in shares) at Dec. 31, 2024 11,155,528 11,155,528    
Balance at beginning of period at Dec. 31, 2024 $ 252,493 $ 71,944 222,823 (42,274)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 24,222   24,222  
Net unrealized gain on securities available for sale, net of tax 9,148     9,148
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7     7
Net unrealized loss on hedging derivative instruments, net of tax (138)     (138)
Comprehensive income 33,239   24,222 9,017
Cash dividends declared (12,326)   (12,326)  
Equity compensation expense 764 $ 764    
Payment to repurchase common stock (in shares)   (11,659)    
Payment to repurchase common stock (284)   (284)  
Issuance of restricted stock (in shares)   43,297    
Proceeds from sale of common stock (in shares)   27,289    
Proceeds from sale of common stock $ 680 $ 680    
Ending balance (in shares) at Sep. 30, 2025 11,214,455 11,214,455    
Balance at end of period at Sep. 30, 2025 $ 274,566 $ 73,388 234,435 (33,257)
Beginning balance (in shares) at Jun. 30, 2025   11,205,861    
Balance at beginning of period at Jun. 30, 2025 265,492 $ 72,907 229,511 (36,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 9,082   9,082  
Net unrealized gain on securities available for sale, net of tax 3,714     3,714
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 20     20
Net unrealized loss on hedging derivative instruments, net of tax (65)     (65)
Comprehensive income 12,751   9,082 3,669
Cash dividends declared (4,149)   (4,149)  
Equity compensation expense 254 $ 254    
Payment to repurchase common stock (in shares)   (225)    
Payment to repurchase common stock (9)   (9)  
Proceeds from sale of common stock (in shares)   8,819    
Proceeds from sale of common stock $ 227 $ 227    
Ending balance (in shares) at Sep. 30, 2025 11,214,455 11,214,455    
Balance at end of period at Sep. 30, 2025 $ 274,566 $ 73,388 $ 234,435 $ (33,257)